Posted 2/22/2012 9:13:41 AM UTC
Updated 2/22/2012 9:13:41 AM UTC
Several companies are in talks with Canadian scientists on commercializing a new method to produce a crucial medical isotope without using feedstock from a nuclear reactor, one of the lead scientists said on Tuesday.
Researchers at the TRIUMF physics lab in Vancouver, British Columbia, say their method, showcased at the American Association for the Advancement of Science meetings in Vancouver on Monday, would produce technetium-99m without using feedstock molybdenum-99, which is mainly produced at nuclear
reactors using enriched uranium.